Quant Healthcare Fund
quant Mutual Fund · FM: Sanjeev Sharma, Ankit A. Pande, Sandeep Tandon, Varun Pattani, Sameer Kate, Ayusha Kumbhat, Yug Tibrewal · INF966L01CD0 · Direct
NAV ₹19.33 AUM ₹397 Cr as of 22 Sep 2026
Portfolio as of Jul 2026 · Last Update: 16-Aug-2026 05:02 PM IST
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.6% | +1.9% | +9.9% | +29.5% | +18.1% | +22.0% | — | 24/234 | 1.51% |
Equity allocation
80.38%
Non-equity allocation (combined)
19.62%
All Equity Holdings (12) as of Jul 2026
| # | Company | Value (₹ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | Glaxosmithkline Pharmaceuticals Ltd | 39.5 | 9.93% | — |
| 2 | Concord Biotech Limited | 38.4 | 9.66% | — |
| 3 | Zydus Wellness Ltd | 37.1 | 9.33% | — |
| 4 | Aster DM Healthcare Limited | 36.7 | 9.25% | — |
| 5 | HFCL Limited | 31.4 | 7.89% | — |
| 6 | SMS Pharmaceuticals Limited | 28.9 | 7.27% | — |
| 7 | Alivus Life Sciences | 28.6 | 7.19% | — |
| 8 | IPCA Laboratories Ltd | 23.6 | 5.93% | — |
| 9 | Pfizer Ltd | 23.1 | 5.82% | — |
| 10 | Aurobindo Pharma Limited | 20.4 | 5.14% | — |
| 11 | Strides Pharma Science Ltd | 10.5 | 2.64% | — |
| 12 | Sumitomo Chemical India Limited | 1.3 | 0.33% | — |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.